Excellagen Plays Leading Role for Cardium Therapeutics, Inc. (CXM)
A major part Cardium’s product candidate portfolio, and the company’s overall strategy, is Excellagen, an acellular biological modulator for advanced wound care management. Cardium’s strategic goal is to develop a portfolio of medical product candidates at various stages of development and to commercialize these products in a timely and effective manner. Excellagen is well down that path, being FDA-cleared, and the company is already seeking commercialization partners for its marketing and sales. Excellagen is a pharmaceutically formulated bovine collagen gel used to facilitate the healing of many types of wounds. During manufacture, the collagen is purified using a specialized process…
